Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Phase II Trial of SMO/AKT/NF2/CDK Inhibitors in Progressive Meningiomas with SMO/AKT/NF2/CDK Pathway MutationsCIRB: Adult CIRB - Early Phase EmphasisLead Group: AllianceStatus: Temporarily Closed to AccrualReview Status: Available to Open
